The JAMA Network today published the results from an Original Investigation on the Novavax COVID-19 vaccine.
In collaboration with the Department of Health and Human Services, Novavax researchers assessed the neutralizing antibody response to its COVID-19 vaccine (NVX-CoV2373) in a phase 3 clinical trial among adolescents from April 26 to June 5, 2021.
Read More
